Find every first-time home buyer grant & down payment assistance program in the U.S.

The purpose of this Broad Agency Announcement (BAA) is to solicit research proposals for funding consideration by the U.S. Army Combat Capabilities Development Command (DEVCOM) Analysis Center (DAC), focusing on data-driven analytical decisions to enhance Army modernization and readiness. Eligible applicants include institutions of higher education, nonprofit organizations, state and local governments, foreign organizations, and for-profit businesses. Interested parties should submit whitepapers and proposals aligned with DAC's research topics, which can be found on the DAC BAA topics website, and are encouraged to check for updates on submission requirements at grants.gov and sam.gov.

The SHINE program aims to promote innovative nonmalignant hematology research relevant to the missions of the NIDDK, NIA, and NHLBI by inviting R01 grant applications in specific areas of basic and early translational hematology research. Eligible applicants include government entities, small and for-profit businesses, educational institutions, nonprofits, and various organizations serving specific communities, with non-domestic entities not eligible to apply. Application details can be found in the NIH Guide to Grants and Contracts, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.

The grant aims to establish Master Cooperative Agreements with participants in the Cooperative Ecosystem Studies Units (CESU) network to support research and resource management related to the National Park System. Eligible applicants must be partners within the CESU network, and those interested in joining can find information at www.cesu.org. Applications can be submitted at any time until the closing date, with instructions available in Section D of the announcement.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, particularly through the validation of transformative technologies that improve outcomes for HLBS-related diseases. Eligible applicants include government entities, nonprofits, educational institutions, for-profit organizations, and various other organizations, including those serving specific communities. Application details are not specified in the provided text, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates, facilitating early-stage translational research and product development. Eligible applicants include various nonprofit organizations, educational institutions, government entities, and for-profit organizations, with specific inclusivity for certain minority-serving institutions. Application details are not explicitly provided, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, specifically through the Catalyze Product Definition initiative focused on identifying potential therapeutic candidates for HLBS diseases. Eligible applicants include various government entities, nonprofits, educational institutions, and for-profit organizations, including small businesses. Application details are not specified in the provided text, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, focusing on early-stage translational support for potential therapeutic candidates targeting HLBS diseases. Eligible applicants include various government entities, small and for-profit businesses, nonprofits, educational institutions, and specific organizations such as HBCUs and tribal colleges. Application details are not provided in the summary, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, focusing on early-stage translational support for HLBS diseases. Eligible applicants include government entities, educational institutions, small and for-profit businesses, and various nonprofit organizations, with specific inclusivity for Native American and minority-serving institutions. Application details are not provided in the summary, but interested parties can contact NIH Grants Information for further inquiries.

The purpose of this grant is to support innovative analyses of existing social science, behavioral, administrative, and neuroimaging data to study drug use behaviors, related disorders, and health service utilization. Eligible applicants include private and public institutions of higher education, government entities, nonprofits, and for-profit organizations, among others. Application details are not specified in the provided text; for further information, applicants should refer to the full opportunity announcement or contact NIH Grants Information.

The grant aims to support innovative analyses of existing social science, behavioral, administrative, and neuroimaging data to enhance understanding of drug use behaviors, related disorders, and health service utilization. Eligible applicants include various educational institutions, nonprofits, government entities, and for-profit organizations, including small businesses and tribal organizations. Application details are not specified in the provided text; interested parties should refer to the full opportunity announcement for more information.

The grant aims to solicit research proposals for funding consideration by the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL), focusing on basic and applied research to support the Army's foundational research mission. Eligible applicants include institutions of higher education, nonprofit organizations, state and local governments, foreign organizations, and for-profit entities. Interested parties can find specific research topics and application details on the ARL BAA topics website.

The purpose of this grant is to support research aimed at understanding and mitigating the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids and their combinations, as well as investigating the long-term pathophysiological effects following such exposure. Eligible applicants include various government entities, educational institutions, small and for-profit businesses, and nonprofits, among others. To apply, interested parties should refer to the full opportunity announcement for specific application details and requirements.